Please assess the completion status of the following clinical trial:

Trial Title: The Effect of D-serine as add-on Therapy in Recent-onset Psychosis

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Age 18-50~* Recent onset psychosis (\< 5 years of overt psychotic symptoms)~* Able to read and understand study procedures and participant's information~Exclusion Criteria:~* Clozapine use~* Suicidal ideation~* Psychotic disorders and symptoms associated with general medical conditions or substance abuse~* BMI \> 30~* Renal impairment (history and creatin levels (\< 80 ug/L for woman and \< 97 ug/L for men))~* Hearing impairment~* Current or past (\< 6 months) enrolment in another clinical trial with the primary outcome to improve symptoms~* Pregnant or lactating women (pregnancy test)

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 50 Years
- Healthy Volunteers: f

Study Arms:
- D-serine group (Type: EXPERIMENTAL): Oral administration of 2g D-serine per day, for 6 weeks.
- Placebo group (Type: PLACEBO_COMPARATOR): Oral administration of 2g Placebo (Mannitol) per day, for 6 weeks.

Based on this trial design, predict the completion outcome and termination type (if applicable).